ENvue Medical, Inc. (FEED)

Import this data to Google Sheets with:

=jivedata("FEED","financials")

Full statements spill as a table. For one cell: =jivedata("FEED","Revenue") or =jivedata("FEED","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

ENvue Medical, Inc.

FEED • CIK 0001326706

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$2,283	$2,558	$2,553	$1,926
Cost of Revenue	$746	$1,050	$2,400	$2,428
Gross Profit	$1,537	$1,508	$153	$-502
Operating Income (Loss)	$-3,436	$-3,582	$-22,889	$-26,246
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-3,682	$-3,686	$-18,492	$-21,416
Income Tax Expense (Benefit)	$29	$19	$-307	$-353
Net Income (Loss) Attributable to Parent	$-3,711	$-3,705	$-18,185	$-21,063
Weighted Average Number of Shares Outstanding, Basic	1,750,109	269,848	628,534	5,077,727
Research and Development Expense	$185	$909	$1,762	$1,284
Selling and Marketing Expense	$864	$720	$2,493	$3,351
General and Administrative Expense	$3,924	$3,461	$7,633	$9,955
Asset Impairment Charges	—	—	$11,154	$11,154
Operating Expenses	$4,973	$5,090	$23,042	$25,744
Dividends, Preferred Stock, Stock	—	—	$1,700	$2,585
Net Income (Loss) Available to Common Stockholders, Basic	$-3,711	$-3,705	$-16,775	$-49,188
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	—	$-13	$-13	$-12
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-3,760	$-3,718	$-18,185	$-21,060

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Assets	$6,674	$3,629	$41,124	$38,405
Liabilities	$2,686	$3,002	$7,627	$7,647
Common Stock, Value, Issued	$2	$3	$1	$8
Additional Paid in Capital	$70,149	$70,505	$124,057	$155,278
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-67	$-80	$-80	$-80
Retained Earnings (Accumulated Deficit)	$-66,096	$-69,801	$-90,481	$-124,448
Stockholders' Equity Attributable to Parent	$3,988	$627	$33,497	$30,758
Cash and Cash Equivalents, at Carrying Value	—	—	$4,224	$1,084
Restricted Cash	—	—	$30	$57
Accounts Receivable, after Allowance for Credit Loss, Current	$318	$98	$289	$205
Inventory, Net	$2,732	$2,191	$2,337	$2,581
Assets, Current	$6,487	$3,331	$7,271	$4,818
Property, Plant and Equipment, Net	$7	$9	$119	$145
Operating Lease, Right-of-Use Asset	$5	$116	$127	$243
Accounts Receivable, after Allowance for Credit Loss, Noncurrent	—	—	$20	$21
Intangible Assets, Net (Excluding Goodwill)	—	—	$4,380	$3,962
Goodwill	—	—	$29,082	$29,082
Assets, Noncurrent	$187	$298	$33,853	$33,587
Accounts Payable, Current	$138	$47	$719	$839
Other Accounts Payable and Accrued Liabilities	$2,265	$2,608	$2,345	$2,905
Loans Payable, Current	—	—	$1,080	$1,080
Contract with Customer, Liability, Current	—	—	$175	$175
Operating Lease, Liability, Current	$5	$52	$89	$162
Liabilities, Current	$2,454	$2,722	$6,660	$7,305
Other Accrued Liabilities, Noncurrent	$217	$216	$132	$143
Operating Lease, Liability, Noncurrent	—	$64	$28	$68
Common Stock, Shares Authorized	40,000,000	40,000,000	40,000,000	40,000,000
Common Stock, Shares, Issued	2,046,307	378,941	1,100,413	8,194,387

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-3,711	$-3,705	$-18,185	$-21,063
Net Cash Provided by (Used in) Operating Activities	$-3,602	$-2,516	$-9,372	$-11,649
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$-49	$-13	$-13	$-12
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$570	$-2,531	$3,502	$-2,919
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	—	$752	$4,254	$5,918
Depreciation, Depletion and Amortization	$1	$1	$897	$951
Cash Acquired from Acquisition	—	—	$148	$148
Share-based Payment Arrangement, Noncash Expense	$293	$356	$356	—
Payments to Acquire Property, Plant, and Equipment	$1	$3	$60	$95
Net Cash Provided by (Used in) Investing Activities	$-1	$-3	$88	$-95
Deferred Income Taxes and Tax Credits	—	—	$-373	$-373
Asset Impairment Charges	—	—	$11,154	$11,154
Increase (Decrease) in Accounts Receivable	$309	$-221	$179	$111
Proceeds from Issuance of Preferred Stock and Preference Stock	—	—	$19,089	$19,089
Payments for Repurchase of Preferred Stock and Preference Stock	—	—	$5,000	$5,000
Increase (Decrease) in Inventories	$557	$-541	$-249	$375
Increase (Decrease) in Accounts Payable, Trade	$72	$-91	$552	$573
Repayments of Notes Payable	—	—	$1,300	$1,300
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities	$-18	$242	$1,025	$966
Repayments of Related Party Debt	—	—	$1,777	$1,777
Increase (Decrease) in Deferred Revenue	$-67	$-46	$160	$0
Proceeds from Short-term Debt	—	—	$360	$360
Proceeds from Stock Options Exercised	$7	$7	$102	$102
IncreaseDecreaseInOperatingLeaseLiability	—	—	$-85	$-157
Proceeds from (Payments for) Other Financing Activities	—	—	$12	$12
Net Cash Provided by (Used in) Financing Activities	$4,222	$1	$12,786	$8,820
Cash and Cash Equivalents, at Carrying Value	—	—	$4,224	$5,888
Restricted Cash	—	—	$30	$30
Interest Paid, Excluding Capitalized Interest, Operating Activities	—	—	$25	$25
Income Taxes Paid, Net	—	—	$52	$49

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("FEED","financials")

Full statements spill as a table. For one cell: =jivedata("FEED","Revenue") or =jivedata("FEED","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.